Ikarian Capital »

Capricor Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 900k 15.21

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Capricor Therapeutics

BlackRock
BlackRock
Vanguard Group
Caption Management
Ikarian Capital
Geode Capital Management
Susquehanna International
State Street Corporation
Northern Trust
Point72 Asset Management
Advisor Group Holdings
Citadel Advisors
Jane Street
Partner Fund Management
LMR Partners

View all funds holding Capricor Therapeutics